We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.72T
| $1.29B | 3.01% |
35,822,912
+90,812
| +0.3% | +$2.99M |
|
2
Microsoft
MSFT
$2.83T
| $821M | 1.92% |
12,468,833
+125,079
| +1% | +$8.02M |
|
|
3
ExxonMobil
XOM
$650B
| $613M | 1.43% |
7,475,584
+202,625
| +3% | +$16.9M |
|
4
Amazon
AMZN
$2.51T
| $563M | 1.32% |
12,704,720
+141,360
| +1% | +$5.89M |
|
|
5
Berkshire Hathaway Class B
BRK.B
$1.06T
| $546M | 1.27% |
3,274,581
+118,043
| +4% | +$19.7M |
|
6
JPMorgan Chase
JPM
$930B
| $545M | 1.27% |
6,207,226
+166,254
| +3% | +$14.7M |
|
7
Johnson & Johnson
JNJ
$624B
| $545M | 1.27% |
4,377,297
+135,573
| +3% | +$16.2M |
|
8
Meta Platforms (Facebook)
META
$1.54T
| $531M | 1.24% |
3,741,605
+54,953
| +1% | +$7.34M |
|
9
AT&T
T
$157B
| $450M | 1.05% |
14,334,706
+414,214
| +3% | +$13M |
|
10
Wells Fargo
WFC
$261B
| $441M | 1.03% |
7,927,811
+185,435
| +2% | +$10.5M |
|
11
GE Aerospace
GE
$362B
| $415M | 0.97% |
2,905,413
+50,177
| +2% | +$7.26M |
|
12
Bank of America
BAC
$430B
| $410M | 0.96% |
17,373,765
+419,734
| +2% | +$9.96M |
|
13
Alphabet (Google) Class C
GOOG
$3.89T
| $409M | 0.96% |
9,863,100
+89,220
| +0.9% | +$3.66M |
|
|
14
Alphabet (Google) Class A
GOOGL
$3.89T
| $394M | 0.92% |
9,305,540
+121,140
| +1% | +$5.09M |
|
15
Procter & Gamble
PG
$342B
| $387M | 0.9% |
4,307,486
+91,900
| +2% | +$8.15M |
|
|
16
Chevron
CVX
$387B
| $365M | 0.85% |
3,401,877
+182,370
| +6% | +$20.5M |
|
17
Verizon
VZ
$183B
| $336M | 0.78% |
6,884,798
+88,988
| +1% | +$4.46M |
|
18
Pfizer
PFE
$143B
| $333M | 0.78% |
10,260,663
+280,431
| +3% | +$8.84M |
|
19
Home Depot
HD
$324B
| $308M | 0.72% |
2,095,643
+19,219
| +0.9% | +$2.73M |
|
20
Comcast
CMCSA
$78.3B
| $304M | 0.71% |
8,078,918
-27,814
| -0.3% | -$1.03M |
|
21
Cisco
CSCO
$444B
| $302M | 0.71% |
8,946,913
+224,040
| +3% | +$7.27M |
|
22
Intel
INTC
$504B
| $301M | 0.7% |
8,334,651
+182,898
| +2% | +$6.62M |
|
23
Walt Disney
DIS
$161B
| $299M | 0.7% |
2,636,185
+31,044
| +1% | +$3.42M |
|
24
Merck
MRK
$322B
| $288M | 0.67% |
4,752,175
+136,039
| +3% | +$8.25M |
|
25
PepsiCo
PEP
$184B
| $283M | 0.66% |
2,531,184
+61,251
| +2% | +$6.57M |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.